Anti-Tumor Effect of Celastrol on Hepatocellular Carcinoma by the circ_SLIT3/miR-223-3p/CXCR4 Axis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Grandhi MS, Kim AK, Ronnekleiv-Kelly SM, et al. Hepatocellular carcinoma: from diagnosis to treatment. Surg Oncol. 2016;25(2):74–85. doi:10.1016/j.suronc.2016.03.00227312032
   PubMed Web of Science ®Google Scholar
• Chen SR, Dai Y, Zhao J, et al. A mechanistic overview of triptolide and celastrol, natural products from Tripterygium wilfordii Hook F. Front Pharmacol. 2018;9:104. doi:10.3389/fphar.2018.0010429491837
   PubMed Web of Science ®Google Scholar
• Chang W, He W, Li PP, et al. Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms. Eur J Pharmacol. 2016;784:173–180. doi:10.1016/j.ejphar.2016.04.04527181068
   PubMed Web of Science ®Google Scholar
• Li PP, He W, Yuan PF, et al. Celastrol induces mitochondria-mediated apoptosis in hepatocellular carcinoma Bel-7402 cells. Am J Chin Med. 2015;43(1):137–148. doi:10.1142/S0192415X1550009325657108
   PubMed Web of Science ®Google Scholar
• Li CW, Chang PY, Chen BS. Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method. Oncotarget. 2016;7(48):79453–79473. doi:10.18632/oncotarget.1310027821810
   PubMedGoogle Scholar
• Li H, Li Y, Liu D, Sun H, Liu J. miR-224 is critical for celastrol-induced inhibition of migration and invasion of hepatocellular carcinoma cells. Cell Physiol Biochem. 2013;32(2):448–458. doi:10.1159/00035445023988648
   PubMedGoogle Scholar
• Xiong DD, Dang YW, Lin P, et al. A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma. J Transl Med. 2018;16(1):220. doi:10.1186/s12967-018-1593-530092792
   PubMed Web of Science ®Google Scholar
• Yu J, Xu QG, Wang ZG, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68(6):1214–1227. doi:10.1016/j.jhep.2018.01.01229378234
   PubMed Web of Science ®Google Scholar
• Li S, Gu H, Huang Y, et al. Circular RNA 101368/miR-200a axis modulates the migration of hepatocellular carcinoma through HMGB1/RAGE signaling. Cell Cycle. 2018;17(19–20):2349–2359. doi:10.1080/15384101.2018.152659930265210
   PubMed Web of Science ®Google Scholar
• Qiu L, Wang T, Ge Q, et al. Circular RNA signature in hepatocellular carcinoma. J Cancer. 2019;10(15):3361–3372. doi:10.7150/jca.3124331293639
   PubMed Web of Science ®Google Scholar
• Ning TZ, Kin WW, Mustafa S, et al. Detection of Entamoeba histolytica in experimentally induced amoebic liver abscess: comparison of three staining methods. Asian Pac J Trop Biomed. 2012;2(1):61–65. doi:10.1016/S2221-1691(11)60191-323569836
   PubMedGoogle Scholar
• Ng EK, Tsang WP, Ng SS, et al. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br J Cancer. 2009;101(4):699–706. doi:10.1038/sj.bjc.660519519638978
   PubMed Web of Science ®Google Scholar
• Wu Y, Xie Z, Chen J, et al. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression. Mol Cancer. 2019;18(1):73. doi:10.1186/s12943-019-1007-130940151
   PubMed Web of Science ®Google Scholar
• Luo H, Vong CT, Chen H, et al. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med. 2019;14:48.31719837
   PubMed Web of Science ®Google Scholar
• Kuchta K, Xiang Y, Huang S, et al. Celastrol, an active constituent of the TCM plant Tripterygium wilfordii Hook.f., inhibits prostate cancer bone metastasis. Prostate Cancer Prostatic Dis. 2017;20(2):156–164. doi:10.1038/pcan.2016.6128195223
   PubMed Web of Science ®Google Scholar
• Tozawa K, Sagawa M, Kizaki M. Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway. Int J Oncol. 2011;39(5):1117–1122. doi:10.3892/ijo.2011.116121850367
   PubMed Web of Science ®Google Scholar
• Barker EC, Kim BG, Yoon JH, et al. Potent suppression of both spontaneous and carcinogen-induced colitis-associated colorectal cancer in mice by dietary celastrol supplementation. Carcinogenesis. 2018;39(1):36–46. doi:10.1093/carcin/bgx11529069290
   PubMed Web of Science ®Google Scholar
• Rajendran P, Li F, Shanmugam MK, et al. Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo. Cancer Prev Res (Phila). 2012;5(4):631–643. doi:10.1158/1940-6207.CAPR-11-042022369852
   PubMed Web of Science ®Google Scholar
• Yao SS, Han L, Tian ZB, et al. Celastrol inhibits growth and metastasis of human gastric cancer cell MKN45 by down-regulating microRNA-21. Phytother Res. 2019;33(6):1706–1716. doi:10.1002/ptr.635930989726
   PubMed Web of Science ®Google Scholar
• Li F, Zhang L, Li W, et al. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway. Oncotarget. 2015;6(8):6001–6013. doi:10.18632/oncotarget.346925749389
   PubMed Web of Science ®Google Scholar
• Wang J, Li X, Lu L, et al. Circular RNA hsa_circ_0000567 can be used as a promising diagnostic biomarker for human colorectal cancer. J Clin Lab Anal. 2018;32(5):e22379. doi:10.1002/jcla.2237929333615
   PubMed Web of Science ®Google Scholar
• Chen LL. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 2016;17(4):205–211. doi:10.1038/nrm.2015.3226908011
   PubMed Web of Science ®Google Scholar
• Pinho JD, Silva GEB, Teixeira Júnior AAL, et al. MIR-107, MIR-223-3P and MIR-21-5P reveals potential biomarkers in penile cancer. Asian Pac J Cancer Prev. 2020;21(2):391–397. doi:10.31557/APJCP.2020.21.2.39132102516
   PubMedGoogle Scholar
• Sugawara S, Yamada Y, Arai T, et al. Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis. J Hum Genet. 2018;63(5):657–668. doi:10.1038/s10038-018-0437-829540855
   PubMed Web of Science ®Google Scholar
• Oksuz Z, Serin MS, Kaplan E, et al. Serum microRNAs; miR-30c-5p, miR-223-3p, miR-302c-3p and miR-17-5p could be used as novel non-invasive biomarkers for HCV-positive cirrhosis and hepatocellular carcinoma. Mol Biol Rep. 2015;42(3):713–720. doi:10.1007/s11033-014-3819-925391771
   PubMed Web of Science ®Google Scholar
• Pratedrat P, Chuaypen N, Nimsamer P, et al. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma. PLoS One. 2020;15(4):e0232211. doi:10.1371/journal.pone.023221132330203
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Behnam Azad B, Nimmagadda S. The intricate role of CXCR4 in cancer. Adv Cancer Res. 2014;124:31–82.25287686
   PubMed Web of Science ®Google Scholar
• Yadav VR, Sung B, Prasad S, et al. Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor. J Mol Med (Berl). 2010;88(12):1243–1253. doi:10.1007/s00109-010-0669-320798912
   PubMed Web of Science ®Google Scholar
• Kun-Ming C, Chih-Hsien C, Chen-Fang L, et al. Potential anticancer effect of celastrol on hepatocellular carcinoma by suppressing CXCR4-related signal and impeding tumor growth in vivo. Arch Med Res. 2020;51(4):297–302. doi:10.1016/j.arcmed.2020.03.00132169299
   PubMed Web of Science ®Google Scholar